1
|
Barat E, Pouant C, Soubieux A, Arrii M, Bardet JD, Chenailler C, Varin R. [Overview of the implementation of pharmaceutical interviews in pharmacies in France: Analysis of responses to a questionnaire]. Therapie 2023:S0040-5957(23)00195-6. [PMID: 38158271 DOI: 10.1016/j.therap.2023.11.010] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/26/2023] [Revised: 11/15/2023] [Accepted: 11/28/2023] [Indexed: 01/03/2024]
Abstract
OBJECTIVE To evaluate the development of pharmaceutical interviews in pharmacies in France, in order to understand the organization implemented, any limitations and the expansion of eligible pathologies. METHOD A dematerialized questionnaire was designed and distributed between November 2022 and February 2023 to pharmacists and pharmacy students in France (mainland and overseas) via a link to a Google Form. RESULTS Ninety-four pharmacists from 8 different regions of France responded to the survey. The 94 responses showed that 56% of pharmacists practiced pharmaceutical interviews. Among pharmacists who practiced interviews, pharmacy owners practiced significantly more interviews than other statuses within the pharmacy (67% vs. 38% P=0.014). No other factor, such as dispensary size or geographical area of practice, had a significant impact on whether or not pharmaceutical interviews were carried out. These talks are often carried out at the patient's request, and 89% of them are accompanied by documents for the patient's attention. For pharmacists who do not carry out interviews, time, staffing and remuneration are the 3 main blocking factors found in both quantitative and verbatim variables. Whether or not pharmacists carry out pharmaceutical interviews, this activity received 87% approval from the 94 respondents, and 84% of them would like to include more chronic disease themes. CONCLUSION The survey shows that pharmacists approve of the pharmaceutical interviewing activity, but it also highlights obvious logistical obstacles linked to a lack of resources. Thus, even among pharmacists who carry out pharmaceutical interviews, this activity is still carried out relatively infrequently on a routine basis, and often by the incumbent pharmacist, who takes on the responsibility of carrying out this activity.
Collapse
Affiliation(s)
- Eric Barat
- Department of Pharmacy, CHU de Rouen, 76031 Rouen, France; Normandie University, UNICAEN, Inserm U1086, 714000 Caen, France.
| | | | | | - Marianne Arrii
- Department of Pharmacy, CHU de Rouen, 76031 Rouen, France
| | - Jean-Didier Bardet
- Université Grenoble Alpes, CNRS, Grenoble INP, UMR5525, TIMC-IMAG, 738000 Grenoble, France
| | | | - Rémi Varin
- Department of Pharmacy, CHU de Rouen, 76031 Rouen, France; UNIROUEN, Inserm U1234, CHU de Rouen, 776031 Rouen, France
| |
Collapse
|
2
|
Vengadessane S, Viglietti D, Sauvageon H, Glotz D, Lefaucheur C, Madelaine I, Deville L. [Medication adherence in renal transplantation: Evaluation, predictive factors and impact on humoral alloreactivity]. Ann Pharm Fr 2023; 81:152-162. [PMID: 35792151 DOI: 10.1016/j.pharma.2022.06.011] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/27/2021] [Revised: 05/30/2022] [Accepted: 06/29/2022] [Indexed: 01/07/2023]
Abstract
OBJECTIVES The aims of this study were to assess medication adherence to immunosuppressive treatment in kidney transplanted patients, to identify predictive factors of medication non-adherence and to analyse its impact on the development of Donor Specific Antibodies (DSA) de novo, biomarkers of rejection in transplant recipients. METHODS A cross-sectional single-centre study was conducted to assess medication adherence to immunosuppressive treatment with the BAASIS (Basel Assessment of Adherence Scale for Immunosuppressives) self-report questionnaire. Univariate and multivariate analyses were performed to determine non-adherence predictive factors and its role in the development of DSA de novo. RESULTS A total of 212 renal transplanted patients completed the BAASIS questionnaire: 36,3 % were non-adherent to their immunosuppressive treatment. Patient's age and taking azathioprine were independent predictors of non-adherence and "married or living together" family status was a protective factor in the multivariate analysis. Medication non-adherence was associated with DSA de novo development in the multivariate model and it multiplied their risk of development by 3. CONCLUSIONS This study, which detected a large proportion of patients who did not adhere to immunosuppressive treatment, highlighted non-adherence predictors and showed the association between non-adherence and development of DSA de novo. In case of non-adherent behavior, it is crucial to set up a personalised support for patients with a multidisciplinary approach of therapeutic education, in which the clinical pharmacist has a role.
Collapse
Affiliation(s)
- Subashini Vengadessane
- Service de pharmacie, hôpital Saint-Louis (APHP), 1, avenue Claude-Vellefaux, 75010 Paris, France.
| | - Denis Viglietti
- Service de néphrologie, hôpital Saint-Louis (APHP), 1, avenue Claude-Vellefaux, 75010 Paris, France
| | - Hélène Sauvageon
- Service de pharmacie, hôpital Saint-Louis (APHP), 1, avenue Claude-Vellefaux, 75010 Paris, France
| | - Denis Glotz
- Service de néphrologie, hôpital Saint-Louis (APHP), 1, avenue Claude-Vellefaux, 75010 Paris, France
| | - Carmen Lefaucheur
- Service de néphrologie, hôpital Saint-Louis (APHP), 1, avenue Claude-Vellefaux, 75010 Paris, France
| | - Isabelle Madelaine
- Service de pharmacie, hôpital Saint-Louis (APHP), 1, avenue Claude-Vellefaux, 75010 Paris, France
| | - Laure Deville
- Service de pharmacie, hôpital Saint-Louis (APHP), 1, avenue Claude-Vellefaux, 75010 Paris, France
| |
Collapse
|
3
|
Nizet P, Touchefeu Y, Pecout S, Cauchin E, Beaudouin E, Mayol S, Fronteau C, Huon JF. Exploring the factors influencing adherence to oral anticancer drugs in patients with digestive cancer: a qualitative study. Support Care Cancer 2022; 30:2591-2604. [PMID: 34812952 PMCID: PMC8794904 DOI: 10.1007/s00520-021-06663-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/03/2021] [Accepted: 10/27/2021] [Indexed: 11/26/2022]
Abstract
PURPOSE The aim of this study was to explore the beliefs, perceptions and representations of patients in order to identify the determinants of oral anticancer drugs adherence and to take action in current practice to improve patient support in digestive oncology. METHODS We constructed a semi-directed interview guide which aimed to explore the patient's relationship with medication, their health history, their experiences at the time of the announcement of treatment, their confidence, their fears, their motivations to adhere to their treatment and the constraints linked to their treatment. The data were analysed and discussed using a thematic approach. RESULTS Seventeen patients agreed to participate in the study. The median age was 60 years. Ten patients had colorectal cancer, 3 patients had hepatocellular carcinoma, 3 patients had gastrointestinal stromal tumour and 1 patient had neuroendocrine pancreatic tumour. We identified five categories of factors influencing adherence: demographic and socioeconomic, disease-related, treatment-related, care system-related, and patient representation and pathways' factors. A majority of patients emphasised the importance of family support in the adherence process and the convenience of per os treatment compared to other intravenous treatments. However, several negative determinants emerged such as the toxicity of the treatment, fears of forgetting to take the medication, difficulties with the galenic formulation and negative beliefs of the family. CONCLUSION This study demonstrates the need to address the different dimensions of the patient in order to understand his or her behaviour with regard to adherence and to identify the levers for improvement.
Collapse
Affiliation(s)
- Pierre Nizet
- Clinical Pharmacy Unit, Nantes University Hospital, 1 Rue Gaston Veil, 44000, Nantes, France.
| | - Yann Touchefeu
- Digestive Oncology, Institut Des Maladies De L'Appareil Digestif, Nantes University Hospital, Nantes, France
| | - Solange Pecout
- Digestive Oncology, Institut Des Maladies De L'Appareil Digestif, Nantes University Hospital, Nantes, France
| | - Estelle Cauchin
- Digestive Oncology, Institut Des Maladies De L'Appareil Digestif, Nantes University Hospital, Nantes, France
| | - Eva Beaudouin
- INSERM, UMR 1246-SPHERE, MethodS in Patients-Centered Outcomes and HEalth ResEarch, Nantes and Tours, France
| | - Séverine Mayol
- Research Department, Nantes University Hospital, Nantes, France
| | - Clémentine Fronteau
- Clinical Pharmacy Unit, Nantes University Hospital, 1 Rue Gaston Veil, 44000, Nantes, France
| | - Jean-François Huon
- Clinical Pharmacy Unit, Nantes University Hospital, 1 Rue Gaston Veil, 44000, Nantes, France
- INSERM, UMR 1246-SPHERE, MethodS in Patients-Centered Outcomes and HEalth ResEarch, Nantes and Tours, France
| |
Collapse
|
4
|
Vion Genovese V, Perceval M, Gauchet A, Buscarlet-jardine L, Pinsault N, Allenet B, Llerena C. Comment améliorer la transition au sein des CRCM : analyse des besoins des patients et de leurs parents lors de l’arrivée en service adulte. Rev Mal Respir 2022. [DOI: 10.1016/j.rmr.2022.01.006] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/21/2020] [Accepted: 12/22/2021] [Indexed: 11/20/2022]
|
5
|
Konieczny C, Schmitt D, Borrel E, Allenet B. [Educational needs and implantable medical devices: how to meet the expectations of patients with coronary stents and heart valves?]. Ann Pharm Fr 2022; 80:749-757. [PMID: 34999123 DOI: 10.1016/j.pharma.2021.12.002] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/24/2021] [Accepted: 12/21/2021] [Indexed: 10/19/2022]
Abstract
At the Grenoble Alpes University Hospital Center, patients with cardiovascular disease have the opportunity to participate in a therapeutic education program in the cardiac rehabilitation department. The objective of this study is to analyze the educational needs of patients with coronary stents and heart valve prostheses. Using an exploratory qualitative method, semi-structured research interviews were conducted with 22 patients and an inductive thematic analysis was performed. We found that emergency surgery does not facilitate the assimilation of information in comparison with a scheduled procedure. The image of the "repaired heart" creates a cognitive conflict with the chronicity imposed by secondary preventive monitoring, a particularity of the implantable medical device. Patients feel that the information they receive is sometimes too voluminous and not adapted to their current needs. Thus, we propose an individualized support model based on the respect of temporality and on the psycho-behavioral functioning of the patient.
Collapse
Affiliation(s)
| | | | - Elisabeth Borrel
- Service de Soins de Suite et Réadaptation de Cardiologie, CHU Grenoble Alpes, Grenoble, France
| | - Benoît Allenet
- Pôle pharmacie, CHU Grenoble Alpes, Grenoble, France; Université Grenoble Alpes, Grenoble, France; CNRS-UGA, TIMC-IMAG UMR 5525, ThEMAS, Grenoble, France Centre Hospitalier Universitaire Grenoble Alpes (CHUGA), France
| |
Collapse
|
6
|
Eukel HN, Morrell B, Holmes SM, Kelsch MP. Simulation Design, Findings, and Call to Action for Managing Difficult Patient Encounters. Am J Pharm Educ 2021; 85:8327. [PMID: 34544736 PMCID: PMC8499658 DOI: 10.5688/ajpe8327] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 08/02/2020] [Accepted: 01/08/2021] [Indexed: 05/22/2023]
Abstract
Objective. To implement and evaluate a laboratory simulation for teaching difficult patient encounter skills to pharmacy students to improve their self-assessed communication abilities and skills in the affective domain.Methods. Twelve simulation scenarios that represented difficult patient encounters in a variety of practice settings were developed. All students completed a self-assessment of their ability to communicate during difficult patient encounters before and after the simulations, and wrote a guided reflection afterward. The impact of the simulation was evaluated using quantitative and qualitative methodology. Three student cohorts were analyzed to determine whether significant change occurred in students' self-perceived communication abilities. Thematic analysis of the qualitative reflection responses was performed.Results. Over three years, three student cohorts of third-year professional students participated in the simulations (n=236). Students self-rated their ability to communicate on a 0-100 scale. Mean self-rating of ability prior to the simulation was 57.7 (SD=15.9) and after was 79.2 (SD=15.2). This mean difference of 21.5 points equates to an approximate 20% increase in self-rated ability. Variability in self-ratings between the cohorts was not significant. Qualitative analysis revealed that the simulation identified for student areas needing further development which in turn promoted self-awareness. Students expressed that learning in the safe, formative environment provided by the simulation contributed to their professional growth and was relevant to their future practice of pharmacy.Conclusion. This simulation fills a gap in skills-based education, addresses the affective domain of the Accreditation Council for Pharmacy Education (ACPE) Standards, transfers easily to schools and colleges of pharmacy. This supports a call to action for pharmacy educators to provide purposeful opportunities for students to practice communicating with patients during difficult encounters.
Collapse
Affiliation(s)
- Heidi N Eukel
- North Dakota State University, School of Pharmacy, Fargo, North Dakota
| | - Briyana Morrell
- University of Indianapolis, School of Nursing, Indianapolis, Indiana
| | - Sarah M Holmes
- University of Indianapolis, School of Nursing, Indianapolis, Indiana
| | - Michael P Kelsch
- North Dakota State University, School of Pharmacy, Fargo, North Dakota
| |
Collapse
|
7
|
Leyrissoux C. Le suivi de l’observance au cœur de l’exercice officinal. Actualités Pharmaceutiques 2020. [DOI: 10.1016/j.actpha.2019.11.007] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|